Active vs. Passive Recovery During High-intensity Training Influences Hormonal Response

被引:17
作者
Wahl, P. [1 ,2 ,3 ]
Mathes, S. [1 ]
Achtzehn, S. [1 ]
Bloch, W. [2 ,3 ]
Mester, J. [1 ,3 ]
机构
[1] German Sport Univ Cologne, Inst Training Sci & Sport Informat, D-50933 Cologne, Germany
[2] German Sport Univ Cologne, D-50933 Cologne, Germany
[3] German Sport Univ Cologne, German Res Ctr Elite Sport, D-50933 Cologne, Germany
关键词
cortisol; testosterone; hGH; VEGF; MIF; HGF; HEPATOCYTE GROWTH-FACTOR; EXERCISE; CORTISOL; INTERVAL;
D O I
10.1055/s-0033-1358474
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The aim of the present study was to compare the effects of active (A) vs. passive (P) recovery during high-intensity interval training on the acute hormonal and metabolic response. Twelve triathletes/ cyclists performed four 4 min intervals on a cycle ergometer, either with A-or P-recovery between each bout. Testosterone, hGH, cortisol, VEGF, HGF and MIF were determined pre, 0', 30', 60' and 180' after both interventions. Metabolic perturbations were characterized by lactate, blood gas and spirometric analysis. A-recovery caused significant increases in circulating levels of cortisol, testosterone, T/C ratio, hGH, VEGF and HGF. Transient higher levels were found for cortisol, testosterone, hGH, VEGF, HGF and MIF after A-recovery compared to P-recovery, despite no differences in metabolic perturbations. A-recovery was more demanding from an athlete's point of view. Based on the data of testosterone, hGH and the T/C-ratio, as well as on the data of VEGF and HGF it appears that this kind of exercise protocol with A-recovery phases between the intervals may promote anabolic processes and may lead to pro-angiogenic conditions more than with P-recovery. These data support the findings that also the long term effects of both recovery modes seem to differ, and that both can induce specific adaptations.
引用
收藏
页码:583 / 589
页数:7
相关论文
共 35 条
  • [1] Effects of recovery mode (active vs. passive) on performance during a short high-intensity interval training program: a longitudinal study
    Ben Abderrahman, Abderraouf
    Zouhal, Hassane
    Chamari, Karim
    Thevenet, Delphine
    de Mullenheim, Pierre-Yves
    Gastinger, Steven
    Tabka, Zouhair
    Prioux, Jacques
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2013, 113 (06) : 1373 - 1383
  • [2] The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing
    Conway, K
    Price, P
    Harding, KG
    Jiang, WG
    [J]. WOUND REPAIR AND REGENERATION, 2006, 14 (01) : 2 - 10
  • [3] Effect of short recovery intensities on the performance during two wingate tests
    Dupont, Gregory
    Moalla, Wassim
    Matran, Regis
    Berthoin, Serge
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2007, 39 (07) : 1170 - 1176
  • [4] Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle
    Enoki, Taisuke
    Yoshida, Yuko
    Lally, James
    Hatta, Hideo
    Bonen, Arend
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2006, 577 (01): : 433 - 443
  • [5] Fukumura D, 2001, CANCER RES, V61, P6020
  • [6] Influence of aging and exercise on endocrine function
    Galbo, H
    [J]. INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM, 2001, 11 : S49 - S57
  • [7] The exercise-induced growth hormone response in athletes
    Godfrey, RJ
    Madgwick, Z
    Whyte, GP
    [J]. SPORTS MEDICINE, 2003, 33 (08) : 599 - 613
  • [8] EFFECT OF ACID-BASE-BALANCE ON THE GROWTH-HORMONE RESPONSE TO ACUTE HIGH-INTENSITY CYCLE EXERCISE
    GORDON, SE
    KRAEMER, WJ
    VOS, NH
    LYNCH, JM
    KNUTTGEN, HG
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1994, 76 (02) : 821 - 829
  • [9] ENDOCRINE RESPONSE TO INTENSE INTERVAL EXERCISE
    GRAY, AB
    TELFORD, RD
    WEIDEMANN, MJ
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1993, 66 (04): : 366 - 371
  • [10] MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF): A PROMISING BIOMARKER
    Grieb, Gerrit
    Merk, Melanie
    Bernhagen, Juergen
    Bucala, Richard
    [J]. DRUG NEWS & PERSPECTIVES, 2010, 23 (04) : 257 - 264